TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · no major macro event
LXRX

Lexicon Pharmaceuticals Inc

Healthcare · Biotechnology

1.80$ -1.6% vs. previous close Closing price · As of: Nov 13, 2026

Ownership

Ownership Structure

Who owns Lexicon Pharmaceuticals Inc (LXRX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 49.2% of the shares are freely tradable; institutional investors hold 82.7%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 82.7%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 1.1%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 49.2%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 11.3%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 445Mio.

Largest Shareholders

Institutions

Institutions LXRX
Name Stake (%) Shares Change (%) Date
Artal Group S A 39.43 175,156,062 +13.2 06/30/2026
FMR Inc 11.66 51,782,045 +14.9 06/30/2026
Siren, L.L.C. 9.97 44,303,518 +0.0 06/30/2026
Sessa Capital, L.P 4.27 18,960,836 +5.8 06/30/2026
BlackRock Inc 3.91 17,348,741 +422.2 06/30/2026
Vanguard Capital Management, LLC 2.23 9,901,208 +4.0 06/30/2026
Point72 Asset Management, L.P. 1.86 8,251,325 +5.6 06/30/2026
Geode Capital Management, LLC 1.41 6,244,372 +97.0 06/30/2026

Funds

Funds LXRX
Name Stake (%) Shares Change (%) Date
Fidelity Growth Company Fund 4.64 20,659,037 +8.5 08/31/2026
Vanguard MStar Total Stk Mkt Idx Invest 1.59 7,083,651 +0.0 09/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings LXRX
Person Role Shares Value As of Type
Exton Michael Chief Executive Officer 328,496 591,293 $ Nov 6, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Nov 6, 2026 Exton Michael Chief Executive Officer Buy 30,064 1.66 49,999

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: November 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?